Fireside Chat on BioPharma Alternative Investment Strategies

March 03, 2026
Alternative investors such as Ares Specialty Healthcare and Blackstone Life Sciences are providing management teams with options for non-dilutive capital to support M&A and R&D to compliment or substitute future equity rounds. This fireside chat will discuss some of the financing options companies should consider, such as private debt, royalties, and R&D project finance. This discussion will also highlight what alternative finance investors are seeking in their partners and the benefits of collaboration for companies.
Speakers
Douglas Dieter
Douglas Dieter, Partner, Portfolio Manager and Co-Head of Ares Specialty Healthcare - Ares Credit Group
Craig Shepherd
Craig Shepherd, Senior Managing Director - Blackstone Life Sciences